Regulatory labyrinth: improving access to medicines for rare diseases

About

At the University of Amsterdam, a policy-focused lecture examines regulatory pathways and barriers to expanding patient access to medicines for rare diseases. The talk covers international frameworks, stakeholder roles, and potential reforms to streamline approvals and funding for breakthrough therapies.